HSPA5 and cancer: Thus, OLN treatment will not only deprive cancer cells of elevated GRP78 in the ER to cope with ER stress, but also suppress its new functions as signaling and transcriptional regulators beyond the ER, impacting proliferation, survival, invasiveness, and resistance to treatment.